Literature DB >> 20002615

Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.

P T Cantey1, G Rao, J Rout, L M Fox.   

Abstract

OBJECTIVES: To assess the performance of an educational campaign to increase adherence to a mass-administered DEC regimen against lymphatic filariasis (LF) in Orissa, and to identify factors that could enhance future campaigns.
METHOD: Randomized cluster survey, comparing areas that did and did not receive the educational campaign, using a household coverage survey and knowledge, attitudes and practices (KAP) survey.
RESULTS: LF MDA coverage for the entire population (n = 3449) was 56% (95% CI: 50.0-61.9). There was no statistical difference between the areas that did and did not receive the educational campaign. The most common barriers to adherence were fear of medication side effects (47.4%) and lack of recognition of one's risk for LF (15.8%). Modifiable, statistically significant, multivariable predictors of adherence were knowing that DEC prevents LF (aOR = 2.6, 95% CI: 1.4-5.1), knowing that mosquitoes transmit LF (aOR = 1.9, 95% CI: 1.1-3.2), and knowing both about the mass drug administration (MDA) in advance and that mosquitoes transmit LF (aOR = 5.4, 95% CI: 2.8-10.4).
CONCLUSIONS: India needs to increase compliance with MDA programmes to reach its goal of interrupting LF transmission. Promoting a simple public health message before MDA distribution, which takes into account barriers to and predictors of adherence, could raise compliance with the LF MDA programme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002615     DOI: 10.1111/j.1365-3156.2009.02443.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  21 in total

1.  High prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemic.

Authors:  Patricia K Foo; Alessandro Tarozzi; Aprajit Mahajan; Joanne Yoong; Lakshmi Krishnan; Daniel Kopf; Brian G Blackburn
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-30       Impact factor: 2.184

2.  Global elimination of lymphatic filariasis: addressing the public health problem.

Authors:  David G Addiss
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

3.  Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

Authors:  Paul T Cantey; Jonathan Rout; Grace Rao; John Williamson; LeAnne M Fox
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

4.  Knowledge, attitudes and practices (KAP) about rabies prevention and control: a community survey in Tanzania.

Authors:  Maganga Sambo; Tiziana Lembo; Sarah Cleaveland; Heather M Ferguson; Lwitiko Sikana; Cleophas Simon; Honorati Urassa; Katie Hampson
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

5.  Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.

Authors:  K D Ramaiah; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

6.  Factors influencing drug uptake during mass drug administration for control of lymphatic filariasis in rural and urban Tanzania.

Authors:  William J Kisoka; Paul E Simonsen; Mwelecele N Malecela; Britt P Tersbøl; Declare L Mushi; Dan W Meyrowitsch
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

7.  Factors determining noncompliance to mass drug administration for lymphatic filariasis elimination.

Authors:  Zinia T Nujum; S Remadevi; C Nirmala; K Rajmohanan; Ps Indu; S Muraleedharan Nair
Journal:  Trop Parasitol       Date:  2012-07

Review 8.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

9.  Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.

Authors:  Philip J Budge; Edmond Sognikin; Amanda Akosa; Els M Mathieu; Michael Deming
Journal:  PLoS Negl Trop Dis       Date:  2016-01-14

10.  Experiences of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India: An Analysis of Focus Group Discussions with Patients, Families, Community Members and Program Volunteers.

Authors:  Tali Cassidy; Caitlin M Worrell; Kristen Little; Aishya Prakash; Inakhi Patra; Jonathan Rout; LeAnne M Fox
Journal:  PLoS Negl Trop Dis       Date:  2016-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.